Sysmex Corp. ADR | |
Stock Exchange | Other OTC |
EPS |
$0.89 |
Market Cap |
$14.07 B |
Shares Outstanding |
418.36 M |
Public Float |
- |
Sysmex Corp. | |
Stock Exchange | Other OTC |
EPS |
$1.78 |
Market Cap |
$14.09 B |
Shares Outstanding |
209.03 M |
Public Float |
- |
Sysmex Corp. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
209.03 M |
Public Float |
- |
Sysmex Corp. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY197.28 |
Market Cap |
JPY1.53 T |
Shares Outstanding |
209.18 M |
Public Float |
150.6 M |
Address |
1-5-1 Wakinohama-Kaigandori Kobe Hyogo 651 Japan |
Employees | - |
Website | http://www.sysmex.co.jp |
Updated | 07/08/2019 |
Sysmex Corp. engages in the development, manufacture, import, export, and sale of clinical laboratory instruments, reagents, and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. |